UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.

Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.

The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.

Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...

The Federal Trade Commission on Friday filed lawsuits against three prescription drug benefit managers or PBMs over concerns ...

Pharmacy-benefit managers owned by CVS, Cigna and UnitedHealth “artificially inflated” prices for lifesaving medications, ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...

The US Federal Trade Commission sued units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. on Friday, accusing ...

Antitrust regulation isn't just about protecting consumers, Federal Trade Commission Chair Lina Khan said Thursday afternoon ...

A new FTC report on how social media and streaming sites collect and monetize their hoards of user data doesn't really ...

Social media platforms are engaging in “vast surveillance” of people online and failing to protect children, according to a ...